Vimarsana
Biggest News Aggregation in the World

Page 4 - Next Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Next Test Today - Breaking & Trending Today

Analysts Set Guardant Health, Inc. (NASDAQ:GH) Target Price at $46.75 - Vimarsana News

Analysts Set Guardant Health, Inc. (NASDAQ:GH) Target Price at $46.75

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average […]

Guardant Health, Inc. (NASDAQ:GH) Receives Average Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Guardant Health, Inc. (NASDAQ:GH) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twelve ratings firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 12 […]

Qsemble Capital Management LP Purchases Shares of 11,505 Guardant Health, Inc. (NASDAQ:GH) - Vimarsana News

Qsemble Capital Management LP Purchases Shares of 11,505 Guardant Health, Inc. (NASDAQ:GH)

Qsemble Capital Management LP acquired a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) during the third quarter, according to its most recent filing with the SEC. The firm acquired 11,505 shares of the company’s stock, valued at approximately $341,000. A number of other hedge funds have also recently bought and sold shares […]

Guardant Health, Inc. (NASDAQ:GH) Receives $48.62 Average Target Price from Analysts - Vimarsana News

Guardant Health, Inc. (NASDAQ:GH) Receives $48.62 Average Target Price from Analysts

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has earned an average rating of “Moderate Buy” from the sixteen ratings firms that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 12 month price […]

Source: wkrb13.com
Guardant Health, Inc. (NASDAQ:GH) Given Consensus Recommendation of "Moderate Buy" by Analysts - Vimarsana News

Guardant Health, Inc. (NASDAQ:GH) Given Consensus Recommendation of "Moderate Buy" by Analysts

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 month price […]